Skip to main content
Top
Published in: Infection 3/2017

01-06-2017 | Case Report

Invasive listeriosis in a patient with several episodes of antibiotic associated colitis presumably due to Clostridium difficile

Authors: Novella Carannante, Pasquale Pagliano, Marco Rossi, Vittorio Attanasio, Carolina Rescigno, Laura Corte, Carlo Tascini, Gianluigi Cardinali

Published in: Infection | Issue 3/2017

Login to get access

Abstract

A 62-year-old man developed a blood stream infection and meningitis due to Listeria monocytogenes, 20 days after an episode of pseudo-membranous colitis. The patient, hospitalized for the first time for transurethral prostatectomy, was readmitted 20 days later with watery diarrhea. Pseudo-membranous colitis was diagnosed and treated successfully, without testing for Clostridium difficile infection (CDI). After 15 more days, the patient developed again diarrhea, fever and confusion. Hospitalized again, blood and cerebrospinal fluid cultures resulted positive for L. monocytogenes. The patient was treated successfully and a diagnosis of recurrent CDI was confirmed following culture and nucleic acid amplification assays both positive for C. difficile. This is the first report of an invasive listeriosis after CDI underlines the importance of taking greater awareness in complicated blood stream infections that may arise after CDI.
Literature
1.
go back to reference Falcone M, Russo A, Iraci F, Carfagna P, Goldoni P, Vullo V, et al. Risk factors and outcomes for bloodstream infections secondary to Clostridium difficile infection. Antimicrob Agents Chemother. 2016;60:252–7.CrossRef Falcone M, Russo A, Iraci F, Carfagna P, Goldoni P, Vullo V, et al. Risk factors and outcomes for bloodstream infections secondary to Clostridium difficile infection. Antimicrob Agents Chemother. 2016;60:252–7.CrossRef
2.
go back to reference Bauer MP, Kuijper E, Van Dissel JT. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect. 2009;15:1067–79.CrossRefPubMed Bauer MP, Kuijper E, Van Dissel JT. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect. 2009;15:1067–79.CrossRefPubMed
3.
go back to reference Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis. 2008;46:S12–8.CrossRefPubMed Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis. 2008;46:S12–8.CrossRefPubMed
4.
go back to reference Bennett JE, Dolin R, Blaser MJ. Principles and practice of infectious diseases. Elsevier Health Sciences; 2014. Bennett JE, Dolin R, Blaser MJ. Principles and practice of infectious diseases. Elsevier Health Sciences; 2014.
5.
go back to reference Zacharioudakis IM, Zervou FN, Pliakos EE, Ziakas PD, Mylonakis E. Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110:381–90.CrossRefPubMed Zacharioudakis IM, Zervou FN, Pliakos EE, Ziakas PD, Mylonakis E. Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110:381–90.CrossRefPubMed
6.
go back to reference El Feghaly RE, Stauber JL, Deych E, Gonzalez C, Tarr PI, Haslam DB. Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection. Clin Infect Dis. 2013;56:1713–21.CrossRefPubMedPubMedCentral El Feghaly RE, Stauber JL, Deych E, Gonzalez C, Tarr PI, Haslam DB. Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection. Clin Infect Dis. 2013;56:1713–21.CrossRefPubMedPubMedCentral
7.
go back to reference Brito GA, Sullivan GW, Ciesla WP, Carper HT, Mandell GL, Guerrant RL. Clostridium difficile toxin A alters in vitro-adherent neutrophil morphology and function. J Infect Dis. 2002;185:1297–306.CrossRefPubMed Brito GA, Sullivan GW, Ciesla WP, Carper HT, Mandell GL, Guerrant RL. Clostridium difficile toxin A alters in vitro-adherent neutrophil morphology and function. J Infect Dis. 2002;185:1297–306.CrossRefPubMed
8.
go back to reference Warren CA, Van Opstal EJ, Riggins MS, Li Y, Moore JH, Kolling GL, et al. Vancomycin treatment’s association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice. Antimicrob Agents Chemother. 2013;57:689–96.CrossRefPubMedPubMedCentral Warren CA, Van Opstal EJ, Riggins MS, Li Y, Moore JH, Kolling GL, et al. Vancomycin treatment’s association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice. Antimicrob Agents Chemother. 2013;57:689–96.CrossRefPubMedPubMedCentral
9.
go back to reference Nerandzic MM, Mullane K, Miller MA, Babakhani F, Donskey CJ. Reduced acquisition and overgrowth of vancomycin-resistant enterococci and Candida species in patients treated with fidaxomicin versus vancomycin for Clostridium difficile infection. Clin Infect Dis. 2012;55:S121–6.CrossRefPubMedPubMedCentral Nerandzic MM, Mullane K, Miller MA, Babakhani F, Donskey CJ. Reduced acquisition and overgrowth of vancomycin-resistant enterococci and Candida species in patients treated with fidaxomicin versus vancomycin for Clostridium difficile infection. Clin Infect Dis. 2012;55:S121–6.CrossRefPubMedPubMedCentral
10.
go back to reference Meini S, Laureano R, Fani L, Tascini C, Galano A, Antonelli A, et al. Breakthrough Lactobacillus rhamnosus GG bacteremia associated with probiotic use in an adult patient with severe active ulcerative colitis: case report and review of the literature. Infection. 2015;43:777–81.CrossRefPubMed Meini S, Laureano R, Fani L, Tascini C, Galano A, Antonelli A, et al. Breakthrough Lactobacillus rhamnosus GG bacteremia associated with probiotic use in an adult patient with severe active ulcerative colitis: case report and review of the literature. Infection. 2015;43:777–81.CrossRefPubMed
11.
go back to reference Wang X-M, Lü X-F, Yin L, Liu H-F, Zhang W-J, Si W, et al. Occurrence and antimicrobial susceptibility of Listeria monocytogenes isolates from retail raw foods. Food Control. 2013;32:153–8.CrossRef Wang X-M, Lü X-F, Yin L, Liu H-F, Zhang W-J, Si W, et al. Occurrence and antimicrobial susceptibility of Listeria monocytogenes isolates from retail raw foods. Food Control. 2013;32:153–8.CrossRef
12.
go back to reference Rea MC, O’Sullivan O, Shanahan F, O’Toole PW, Stanton C, Ross RP, et al. Clostridium difficile carriage in elderly subjects and associated changes in the intestinal microbiota. J Clin Microbiol. 2012;50:867–75.CrossRefPubMedPubMedCentral Rea MC, O’Sullivan O, Shanahan F, O’Toole PW, Stanton C, Ross RP, et al. Clostridium difficile carriage in elderly subjects and associated changes in the intestinal microbiota. J Clin Microbiol. 2012;50:867–75.CrossRefPubMedPubMedCentral
13.
go back to reference Corr SC, Gahan CG, Hill C. Impact of selected Lactobacillus and Bifidobacterium species on Listeria monocytogenes infection and the mucosal immune response. FEMS Immunol Med Microbiol. 2007;50:380–8.CrossRefPubMed Corr SC, Gahan CG, Hill C. Impact of selected Lactobacillus and Bifidobacterium species on Listeria monocytogenes infection and the mucosal immune response. FEMS Immunol Med Microbiol. 2007;50:380–8.CrossRefPubMed
14.
go back to reference Cho K, Surh CD. The role of commensal microbiota on CD8 T cell response to Listeria monocytogenes infection. The Journal of Immunology. 2016;196:208–17.CrossRef Cho K, Surh CD. The role of commensal microbiota on CD8 T cell response to Listeria monocytogenes infection. The Journal of Immunology. 2016;196:208–17.CrossRef
Metadata
Title
Invasive listeriosis in a patient with several episodes of antibiotic associated colitis presumably due to Clostridium difficile
Authors
Novella Carannante
Pasquale Pagliano
Marco Rossi
Vittorio Attanasio
Carolina Rescigno
Laura Corte
Carlo Tascini
Gianluigi Cardinali
Publication date
01-06-2017
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 3/2017
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-017-1013-4

Other articles of this Issue 3/2017

Infection 3/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.